|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000219070
|
MMP2
|
NA
|
Myeloid-derived growth factor
|
primary sj?gren syndrome
|
up-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB08439
|
Parecoxib
|
hepatocellular carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00254
|
Doxycycline
|
pressure ulcers
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
colon cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
esophageal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
colon cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
glioma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
hepatoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
giant cell tumor of the spine
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
endometrial cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
ovarian cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
osteosarcoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
primary lung adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
ovarian cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
oral squamous cell cancer (oscc)
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
glioblastoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
non-small cell lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
laryngeal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
melanoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
esophageal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
glioma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
ovarian cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
oral tongue squamous cell carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
NA
|
osteosarcoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000219070
|
MMP2
|
DB08162
|
Fasudil
|
glioblastoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Reactive oxygen species
|
restenosis after percutaneous coronary intervention
|
up-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB16101
|
Baicalein
|
gallbladder carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB08880
|
Teriflunomide
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB01097
|
Leflunomide
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00624
|
Testosterone
|
chronic inflammation
|
up-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00624
|
Testosterone
|
infection
|
up-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB12025
|
Triptolide
|
degenerative intervertebral disc
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
GNF351
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB11242
|
Gelatin
|
abdominal aortic aneurysms
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
3-Aminobenzamide
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB06589
|
Pazopanib
|
hepatic fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB12412
|
Gemigliptin
|
type 2 diabetic
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Periplocoside
|
vulvar squamous cell carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Ginseng extract
|
hepatic fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00254
|
Doxycycline
|
abdominal aortic aneurysm
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Grape seed polyphenols
|
abdominal aortic aneurysm
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB06737
|
Zaltoprofen
|
chondrosarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Agkistrodon acutus
|
osteoarthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Matrine
|
prostatic cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00254
|
Doxycycline
|
atrial fibrillation
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Notoginsenoside
|
brain microcirculation disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00136
|
|
colon aberrations
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00136
|
Calcitriol
|
colon cancer cell
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Lathyrol derivatives
|
non-small cell lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB01275
|
Hydralazine
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00381
|
Amlodipine
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB13919
|
Candesartan
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00584
|
Enalapril
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB01275
|
Hydralazine
|
left ventricular hypertrophy
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00381
|
Amlodipine
|
left ventricular hypertrophy
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB13919
|
Candesartan
|
left ventricular hypertrophy
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00584
|
Enalapril
|
left ventricular hypertrophy
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB15584
|
Luteolin
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Shikonin
|
gastric cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Chelerythrine
|
hepatocellular carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Berbamine
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00515 (APRD00359)
|
Cisplatin
|
ovarian cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
Solasodine
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB01238 (APRD00638)
|
Aripiprazole
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB11672
|
Curcumin
|
acute monocytic leukemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB12843
|
Oleandrin
|
osteosarcoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00594 (APRD00790, EXPT00514)
|
Amiloride
|
cervical cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
NA
|
FK866
|
gastric cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000219070
|
MMP2
|
DB00877 (APRD00178, DB02439)
|
Sirolimus(Rapamycin)
|
cholangiocarcinoma
|
down-regulated
|
validated
|
more...
|